Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSusanne Rogers

About this trial

The research question is whether a single fraction of preoperative radiosurgery can reduce the incidence of leptomeningeal disease 12 months following resection of a brain metastasis (BM) as compared with 5 fractions of postoperative stereotactic radiotherapy.

Eligibility criteria

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

Age ≥18

Karnofsky performance status ≥60

Disqualifiers

Radiosensitive histology: germ cell tumour, lymphoma, multiple myeloma

>10 mm midline shift, effacement of the 4th ventricle or other sign of raised intracranial pressure requiring urgent decompressive surgery

More than 4 brain metastases or the diameter of the metastasis for resection >4.0 cm.

More than 1 metastasis requiring resection

Trial design

Treatments tested in this trial

  • preoperative radiosurgery
  • postoperative hypofractionated stereotactic radiotherapy

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Susanne Rogers

Lead sponsor

Kantonsspital Aarau

Sponsor institution

University of Basel

Collaborator